advertisement
Diagnostics (Basel, Switzerland) 11
Showing records 1 to 11 | Display all abstracts in Diagnostics (Basel, Switzerland)86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Dal Monte M
Diagnostics (Basel, Switzerland) 2020; 10:
86294 Tear Break-Up Time and Seasonal Variation in Intraocular Pressure in a Japanese Population
Ayaki M
Diagnostics (Basel, Switzerland) 2020; 10:
86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Cammalleri M
Diagnostics (Basel, Switzerland) 2020; 10:
86294 Tear Break-Up Time and Seasonal Variation in Intraocular Pressure in a Japanese Population
Negishi K
Diagnostics (Basel, Switzerland) 2020; 10:
86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Pezzino S
Diagnostics (Basel, Switzerland) 2020; 10:
86294 Tear Break-Up Time and Seasonal Variation in Intraocular Pressure in a Japanese Population
Yuki K
Diagnostics (Basel, Switzerland) 2020; 10:
86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Corsaro R
Diagnostics (Basel, Switzerland) 2020; 10:
86294 Tear Break-Up Time and Seasonal Variation in Intraocular Pressure in a Japanese Population
Kawashima M; Uchino M
Diagnostics (Basel, Switzerland) 2020; 10:
86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Pescosolido N
Diagnostics (Basel, Switzerland) 2020; 10:
86294 Tear Break-Up Time and Seasonal Variation in Intraocular Pressure in a Japanese Population
Tsubota K
Diagnostics (Basel, Switzerland) 2020; 10:
86347 Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
Bagnoli P; Rusciano D
Diagnostics (Basel, Switzerland) 2020; 10:
